Je was op zoek naar: oksibutininas (Lithouws - Engels)

oksibutininas
oxybutynin

kentera oksibutininas
kentera oxybutynin

veiklioji medžiaga yra oksibutininas.
the active substance is oxybutynin.

oksibutininas gali slopinti prokinetisk gydym.
oxybutynin may antagonize prokinetic therapies.

veiklioji sio preparato medziaga -oksibutininas.
the active substance is oxybutynin.

absorbavęsis oksibutininas plačiai pasklinda kūno audiniuose.
oxybutynin is widely distributed in body tissues following systemic absorption.

oksibutininas gali sukelti mieguistum arba sutrikdyti regjim.
oxybutynin may cause drowsiness or blurred vision.

pasiskirstymas absorbavsis oksibutininas placiai pasklinda kno audiniuose.
distribution oxybutynin is widely distributed in body tissues following systemic absorption.

veiklioji kentera medziaga, oksibutininas, yra anticholinerginis vaistas.
the active substance in kentera, oxybutynin, is an anticholinergic medicine.

kentera 3,9 mg / 24 val. transdermalinis pleistras oksibutininas
kentera 3.9 mg / 24 hours transdermal patch oxybutynin

kentera 90,7 mg/g gelis dozavimo pompoje oksibutininas
kentera 90.7 mg/g gel in metering pump oxybutynin

oksibutininas ­ tai raceminis r ir s-izomer misinys (50: 50) .
oxybutynin is a racemic (50:50) mixture of r-and s-isomers.

veiklioji pleistro medziaga oksibutininas istirpinta ploname pleistr prie odos prilipdancios lipniosios medziagos sluoksnyje.
oxybutynin, the active substance in the patch, is dissolved in the thin layer of adhesive, which is used to stick the patch to your skin.

39 cm2 ploto pleistras per 24 val. nominaliai išskiria 3.9 mg oksibutinino.
the area of the patch is 39 cm2, releasing a nominal 3.9 mg of oxybutynin per 24 hours.